Breaking News
Sort by:
Top Post
Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection
Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]
Optibrium Shows Deep Learning to Successfully Predict Human Panel-based Sensory Perception of Novel Compounds Used for Flavours and Fragrances
Optibrium Limited, a leading provider of software and artificial intelligence (AI) solutions for drug discovery, […]
Novarad Partners with CureMetrix to Advance AI-Driven Mammography
Novarad, a leader in the development of medical imaging software, today announced a partnership with […]
Therapixel Receives FDA Clearance for Use of its AI-based Breast Cancer Screening Software MammoScreen® on Digital Breast Tomosynthesis
Therapixel, a company leading the use of AI-based products for women’s health, announces it has […]
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising […]
Main Street Radiology Adopts Agamon's AI-Engine to Boost Follow-Ups Automatically
Medical imaging services provider Main Street Radiology (MSR) is building stronger relationships with referring physicians […]
Sanofi Invests $180 Million Equity in Owkin ’s Artificial Intelligence and Federated Learning to Advance Oncology Pipeline
Sanofi announced today an equity investment of $180 million and a new strategic collaboration with […]
VIDA Streamlines Respiratory Clinical Trials with Artificial Intelligence (AI)
VIDA Diagnostics, Inc. (VIDA) is further removing friction in respiratory clinical trials with the introduction of […]
MoveAI™ Technology by WizeCare Shapes the Future of Physical Rehabilitation
WizeCare, a health technology company leading the way in the delivery of intelligent, accessible, and exciting […]
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced […]
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more